ProCE Banner Activity

Advances in Genetic Obesity Management Across Syndromic and Monogenic Obesity

Slideset Download

In these unlocked downloadable slides, experts provide a review of the genetic causes of obesity, utility of genetic testing, and evidence for and appropriate use of medications for treatment of genetic obesity disorders.

Released: November 01, 2022

Expiration: October 31, 2023

Share

Faculty

Stephanie Sisley

Stephanie Sisley, MD

Assistant Professor
Department of Pediatrics
Baylor College of Medicine
Houston, Texas

Fatima Cody Stanford

Fatima Cody Stanford, MD, MPH, MPA, MBA

Associate Professor
Departments of Medicine and Pediatrics
Harvard Medical School
Obesity Medicine Physician Scientist
Neuroendocrine Unit and Pediatrics
Endocinology
Department of Medicine
Massachusetts General Hospital
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Rhythm Pharmaceuticals Inc

Faculty Disclosure

Primary Author

Stephanie Sisley, MD

Assistant Professor
Department of Pediatrics
Baylor College of Medicine
Houston, Texas

Fatima Cody Stanford, MD, MPH, MPA, MBA

Associate Professor
Departments of Medicine and Pediatrics
Harvard Medical School
Obesity Medicine Physician Scientist
Neuroendocrine Unit and Pediatrics
Endocinology
Department of Medicine
Massachusetts General Hospital
Boston, Massachusetts

Fatima Cody Stanford, MD, MPH, MPA, MBA: consultant/advisor/speaker: Boehringer Ingelheim, Calibrate, Curraz, Gelesis, Lilly, Novo Nordisk, Pfizer, Rhythm